{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:33:48Z","timestamp":1780680828216,"version":"3.54.1"},"reference-count":0,"publisher":"BMJ","issue":"7369","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,10,19]]},"DOI":"10.1136\/bmj.325.7369.864","type":"journal-article","created":{"date-parts":[[2002,10,18]],"date-time":"2002-10-18T09:09:58Z","timestamp":1034932198000},"page":"864-864","source":"Crossref","is-referenced-by-count":59,"title":["Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial"],"prefix":"10.1136","volume":"325","author":[{"given":"P.","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","container-title":["BMJ"],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.325.7369.864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:31:34Z","timestamp":1601119894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.325.7369.864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,19]]},"references-count":0,"journal-issue":{"issue":"7369"},"URL":"https:\/\/doi.org\/10.1136\/bmj.325.7369.864","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,19]]}}}